Patent Law Weblog
recent posts
- Apple v. Squires: USPTO Director Has Unlimited Discretion on IPR Institution
- The Ghost in the Machine: Why GenAI Can Be Both a Brilliant Researcher and a Terrible Advocate
- Bayer Files Suit Against Trio of COVID-19 Vaccine Makers
- Allen v. Cooper (4th Cir. 2026)
- To Require an Inventor ID, or Not to Require an Inventor ID – That Is the Question
about
Month: June 2007
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Pfizer Inc. et al v. Teva Pharmaceuticals USA Inc.1:07-cv-00360; filed June 7, 2007 in the District Court of Delaware Infringement of U.S.…
-
By Kevin E. Noonan — The emotionally-charged phrase "patenting life" has been used by Michael Crichton, Lori Andrews, and others to raise the temperature on the debate over whether biotechnology patents (usually involving isolated genes) should be banned or curtailed. Although absent from the bill introduced by Congressman Becerra (at right) – who…
-
By Donald Zuhn — Last Wednesday, the Senate Judiciary Committee conducted a hearing on "Patent Reform: The Future of American Innovation." Testifying at the hearing were Jon W. Dudas, Undersecretary of Commerce for Intellectual Property and Director of the U.S. Patent and Trademark Office; Bruce G. Bernstein, Chief Intellectual Property and Licensing Officer…
-
By Donald Zuhn — On June 3, 2007, QIAGEN N.V. and Digene Corp. announced that the two companies would be combining to form a molecular diagnostics company worth approximately US$16.6 billion. The merger agreement calls for QIAGEN to acquire all of Digene’s stock for a combination of cash and QIAGEN common stock, with…
-
By Donald Zuhn — Last Thursday, Agilent Technologies Inc. announced that it had completed its $250 million acquisition of Stratagene Corp. Agilent had announced the agreement to acquire Stratagene, which develops, manufactures, and markets life science research and diagnostic products, two months earlier. Agilent bills itself as the world’s premier measurement company, specializing…
-
June 13, 2007 – "The Scope and Implications of the Supreme Court's Ruling in KSR v. Teleflex on the Doctrine of Patent Obviousness" (Practising Law Institute) June 21-22, 2007 – Technology IP Due Diligence Conference (American Conference Institute) – San Francisco, CA*** June 21-22, 2007 – Pharma/Biotech Patent Boot Camp (American Conference Institute) – New…
-
By Christopher P. Singer — The USPTO has issued a notice discussing changes to its Electronic Notification of Outgoing Correspondence pilot program, better known as "e-Office actions." The changes are in response to feedback the Office has received from pilot program participants. The pilot program was launched on December 16, 2006, and is…
-
By Donald Zuhn — The USPTO has announced that it is starting a pilot program to determine whether the submission of documents and comments by the public (i.e., "collaborative review") might be useful to examiners as a way of locating prior art that might not otherwise be located by the Patent Office during…
-
By Christopher P. Singer — The USPTO has announced that it is simplifying the priority document exchange program, effective as of the publication of the notice. This program allows for the exchange of priority documents between the USPTO and the EPO (and soon, the JPO as well) in order to perfect a priority…
-
Viral Mercenaries to The Rescue By Baltazar Gomez — On May 29, 2007, Oncolytics Biotech Inc. of Calgary, Canada announced the grant of U.S. Patent No. 7,223,585, the biotech company’s twenty-first U.S. patent. The ‘585 patent, entitled "Viral Purification Methods," covers the production and purification of viruses, specifically human reovirus (Respiratory Enteric Orphan…
Patent Docs 